Genentech Newswire

Comprehensive Real-Time News Feed for Genentech.

Results 1 - 20 of 237 in Genentech

  1. IBM Supercomputer Will Guide Cancer Treatment at 14 HospitalsRead the original story w/Photo

    13 min ago | News Max

    ... Although genetic profiling is standard in melanoma and some lung cancers, where drugs such as Zelboraf from the Genentech unit of Roche target the driver mutation, in most common tumors traditional chemotherapy and radiation remain the standard of ...

    Comment?

  2. IBM's Watson to guide cancer therapies at 14 centersRead the original story w/Photo

    1 hr ago | Reuters

    ... Although genetic profiling is standard in melanoma and some lung cancers, where drugs such as Zelboraf from the Genentech unit of Roche Holding AG ( "When institutions do genetic sequencing, only about half the cases come back with something ...

    Comment?

  3. Repairs To The Heart: The Needle Or The Knife?Read the original story w/Photo

    Yesterday | Seeking Alpha

    ... as an organ that might be repaired using such technologies. Indeed, my recollection is that about a decade ago Genentech CEO Arthur Levinson said that his company would become a stem cell company and fix hearts using this technology within 10 years. ...

    Comment?

  4. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Yesterday | Business Wire

    ... Horn, allait prendre la parole a la conference du 25eme anniversaire de NewYorkBIO le 5 mai dans le cadre... )--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced Futurelab, a collaborative program with the South ...

    Comment?

  5. Video: Genentech Announces New STEM Education Initiative to Support South San Francisco SchoolsRead the original story

    Yesterday | ClipSyndicate

    SOUTH SAN FRANCISCO, Calif.-- --Genentech, a member of the Roche Group , today announced Futurelab, a collaborative program with the South San Francisco Unified School District to support science, technology, engineering and mathematics education. Futurelab builds on Genentech's long-standing commitment to science education and seeks to make a difference in the lives of local students, empower teachers, and inspire employees.

    Comment?

  6. Genentech Announces New STEM Education Initiative to Support South San Francisco SchoolsRead the original story

    Yesterday | Business Wire

    Futurelab builds on Genentech's long-standing commitment to science education and seeks to make a difference in the lives of local students, empower teachers, and inspire employees. Through the program, South San Francisco students at every grade level will have opportunities to engage in STEM.

    Comment?

  7. Personalizing targeted immunotherapyRead the original story w/Photo

    Thursday Apr 30 | PhysOrg Weblog

    ... developed by four pharmaceutical companies (Bristol-Myers Squibb Company, Merck & Co. Inc., AstraZeneca PLC, and Genentech, Inc.) and two diagnostic companies (Agilent Technologies, Inc./Dako Corp and Roche/Ventana Medical Systems, Inc.). The goal ...

    Comment?

  8. Buck Institute partners with Google's Calico in quest for longevityRead the original story w/Photo

    Wednesday Apr 29 | The Business Journal

    ... on aging and the biotech industry to work together." Calico's CEO is Arthur Levinson, former CEO and chairman of Genentech, and current board member of Apple. Levinson, 65, in 1980 started at Genentech, which has a major research facility in Solano ...

    Comment?

  9. Calico taps space, aging research deal with Buck InstituteRead the original story w/Photo

    Tuesday Apr 28 | Business Journal

    the Google Inc.-backed aging research company led by former Genentech Inc. CEO Art Levinson - signed a research deal with the Buck Institute for Research on Aging that includes setting up shop at the institute's Novato complex. Terms of the pact ...

    Comment?

  10. Newly released market study: Genentech, Inc. - Product Pipeline Review - 2015Read the original story

    Sunday Apr 26 | PR-inside.com

    This report provides comprehensive information on the current therapeutic developmental pipeline of Genentech, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action , route of administration and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

    Comment?

  11. Zynga Appoints Louis J. Lavigne, Jr. to Board of DirectorsRead the original story

    Thursday Apr 23 | Digital Game Developer

    Zynga Inc. , a leading provider of social game services, today announced that Louis J. Lavigne, Jr., former Genentech Inc. Chief Financial Officer, has joined the company's Board of Directors. Lavigne brings extensive experience in business operations and management, strategy, finance, accounting and public company governance to Zynga's Board.

    Comment?

  12. Immune therapy tested in study of women with triple-negative breast cancerRead the original story

    Thursday Apr 23 | Medical News Today

    ... system and raise the alarm for destruction by the immune system. MPDL3280A is being developed and manufactured by Genentech Inc., which also funded the study. Emens has received research funding from Genentech for another clinical trial and a ...

    Comment?

  13. Genentech makes cell line identification faster and cheaperRead the original story w/Photo

    Wednesday Apr 22 | Drug Researcher

    ... blueprint sets out a way of combatting problems of cell line misidentification, contamination and poor annotation. Genentech began by cleaning up existing lists of cell lines using a standard STR test, gathering DNA profiles from seven DNA ...

    Comment?

  14. Roche sales rise, lifted by cancer drugsRead the original story w/Photo

    Wednesday Apr 22 | MarketWatch

    Roche Holding AG said strong growth of its core cancer franchise pushed sales 3% higher in the first quarter, prompting the Swiss drug giant to confirm its guidance for the year and suggest it will raise its dividend. Basel-based Roche said sales rose to 11.83 billion Swiss francs in the quarter ended March 31, beating an analyst forecast of 11.508 billion francs.

    Comment?

  15. Experimental immune therapy generally safe, well-tolerated in women...Read the original story w/Photo

    Tuesday Apr 21 | Medical News

    ... system and raise the alarm for destruction by the immune system. MPDL3280A is being developed and manufactured by Genentech Inc., which also funded the study. Emens has received research funding from Genentech for another clinical trial and a ...

    Comment?

  16. Roche Breast-Cancer Drug Challenges Merck in Immunotherapy RaceRead the original story

    Monday Apr 20 | The Washington Post

    ... but important effects on the immune system," Dan Chen, head of cancer immunotherapy development at Roche's Genentech division, said in a phone interview. "Avastin is a beautiful example of that. But we don't think it's going to end with Avastin. We ...

    Comment?

  17. Experimental Immune Therapy Tested in Preliminary Study of Women with Triple-Negative Breast CancerRead the original story

    Monday Apr 20 | Newswise

    ... system and raise the alarm for destruction by the immune system. MPDL3280A is being developed and manufactured by Genentech Inc., which also funded the study. Emens has received research funding from Genentech for another clinical trial and a ...

    Comment?

  18. New upscale hotel takes shape: South City planners approve modern hotel in Britannia Cove projectRead the original story w/Photo

    Saturday Apr 18 | San Mateo Daily Journal

    ... fill a need." Pieters, who represents the team that will operate the hotel, said his firm received blessing from Genentech on the unique character of the building, since the biotechnology company will likely drive a significant portion of the ...

    Comment?

  19. Massachusetts Biotechnology Council, Inc. Welcomes Seven New Board MembersRead the original story

    Thursday Apr 16 | BioSpace

    ... including President of R&D since 2010 and CSO since 2003. Prior to ARIAD, he was a postdoctoral fellow at Genentech Inc. Dr. Clackson received his PhD in biology from Cambridge University and his BA in biochemistry from Oxford University. Chris ...

    Comment?

  20. Local Artist's Doughnut Habit Scores Big Biotech MoneyRead the original story

    Wednesday Apr 15 | Eater

    ... paintings have made their way into homes and businesses across the Bay Area, most notably adorning a new Genentech building in South San Francisco, built on the site of a former bakery. The multi-billion dollar biotechnology corporation purchased ...

    Comment?